Company intelligence / Profile preview

FetTech

Winston-Salem, North Carolina, United Statesfettech.com ↗

Ownership: Private
Development stage: Commercial

Overview

FetTech’s MTP technology has been FDA-cleared for wound healing applications since 2018 and used in hospitals across the US. Early studies show strong potential in skin rejuvenation/aesthetics and as an antiviral agent against enveloped viruses. Additional pipeline programs are at pre-clinical or early clinical stages.

Therapeutic areas: OtherDermatologyRheumatologyCardiovascularNeurologyInfectious Diseases
Modalities: BiologicExtracellular matrix biomaterial (ECM)Cell-free regenerative therapy
Industry: Biotech

Drug pipeline

5 assets

MTP Orthopedic

Preclinical

4 more assets in the full pipeline.

Request access →

Partnerships

Government agencies involved in anti-virus studies with MTP gel

Beyond the preview

Go deeper on FetTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FetTech.

Explore the full profile